(1 - 29 from 47
)
St. Paul's Synovis to be acquired for $325M - StarTribune.com
www.startribune.com
The medical device company's CEO says buyer Baxter will maintain a Minnesota presence.
Drug fails to slow Alzheimer's in large study | Fox News
www.foxnews.com
Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of
Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta | Reuters
www.reuters.com
Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading...
Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M
www.genengnews.com
Baxter will pay Coherus $30 million upfront and up to $216 million toward milestones, hoping to speed up its expansion into biosimilars
sorted by relevance / date